Precipio (NASDAQ:PRPO)’s share price passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $3.16 and traded as low as $2.08. Precipio shares last traded at $2.09, with a volume of 21,234 shares changing hands.
Separately, Maxim Group assumed coverage on Precipio in a report on Friday, November 22nd. They issued a “buy” rating and a $4.00 target price on the stock.
The company has a quick ratio of 0.60, a current ratio of 0.64 and a debt-to-equity ratio of 0.05. The firm’s 50-day moving average is $2.28 and its 200 day moving average is $3.07.
About Precipio (NASDAQ:PRPO)
Precipio, Inc, a cancer diagnostics company, provides diagnostic products and services to the oncology market. It also develops a platform to eradicate the problem of misdiagnosis within academic institutions. In addition, the company delivers diagnostic information to physicians and their patients. It has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment, as well as PerkinElmer.
Featured Story: Do Tariffs Work?
Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.